Molecular genetics of Staphylococcus epidermidis biofilms on indwelling medical devices

V Vadyvaloo1, M Otto

  • 1Rocky Mountain Laboratories, NIAID/NIH, Hamilton, MT, USA.

Insights

Staphylococcus epidermidis forms biofilms on medical devices, causing difficult-to-treat infections. Understanding biofilm formation mechanisms is crucial for developing new therapies against this opportunistic pathogen.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Biotechnology

Background:

  • Staphylococcus epidermidis is a major cause of foreign body infections and hospital-acquired sepsis.
  • Its pathogenicity is linked to biofilm formation on indwelling polymeric devices.
  • Biofilms confer resistance to antibiotics and host immune defenses, complicating treatment.

Purpose of the Study:

  • To explore the complex mechanisms underlying Staphylococcus epidermidis biofilm formation.
  • To identify key bacterial factors and regulatory systems involved in biofilm development.
  • To provide insights for developing novel anti-staphylococcal therapeutics.

Main Methods:

  • Review of current literature on Staphylococcus epidermidis pathogenicity.
  • Analysis of known cell surface factors (e.g., polysaccharide intercellular adhesin, AtlE) in adherence and accumulation.
  • Examination of global regulators (e.g., agr quorum sensing, sarA, sigB) in biofilm regulation.

Main Results:

  • Staphylococcus epidermidis utilizes specific cell surface factors for biofilm adherence and structure.
  • Global regulatory systems, including quorum sensing, significantly control biofilm formation.
  • Understanding these mechanisms is vital for therapeutic strategies.

Conclusions:

  • Staphylococcus epidermidis biofilm formation is a multifactorial process involving specific adhesion molecules and global regulators.
  • Targeting these mechanisms offers potential for new treatments against device-associated infections.
  • Further research into these pathways is essential for combating antibiotic resistance.

Related Concept Videos

Biofilms01:29

Biofilms

Biofilms are complex communities of microorganisms encased in a self-produced extracellular polysaccharide matrix attached to surfaces. These microbial consortia can include single or multiple species, providing enhanced survival benefits by forming organized, multilayered structures.The formation of biofilms occurs through four key stages: attachment, colonization, development, and dispersal.During attachment, free-swimming planktonic cells adhere to a surface, often facilitated by...
Bacterial Signaling01:30

Bacterial Signaling

Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...